Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- Overview of Neurostimulation
- Types of Neurostimulation Technologies
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation (Sns)
- Vagus Nerve Stimulation
- Hypoglossal Nerve Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation (Tms)
- Other Neurostimulation Technologies
- Therapeutic Applications for Neurostimulation
- Chronic Pain Management
- Neurological Disorders
- Urinary and Fecal Incontinence
- Obstructive Sleep Apnea
- Chronic Migraine and Headache
- Cardiovascular Diseases
- Gastrointestinal Disorders
- Obesity
- Psychiatric Disorders
- Technological Developments
- Mri Compatibility
- Rechargeable and Non-Rechargeable Devices
Chapter 4 Market Dynamics
- Market Trends
- Drivers
- Market Restraints
Chapter 5 Market Breakdown by Technology/Device Type
- Global Market for Neurostimulation Devices by Type
- Spinal Cord Stimulation (Scs) Devices
- Transcutaneous Electrical Nerve Stimulation (Tens) Devices
- Deep Brain Stimulation (Dbs) Devices
- Sacral Nerve Stimulation (Sns) Devices
- Vagus Nerve Stimulation (Vns) Devices
- Hypoglossal Nerve Stimulation (Hgns) Devices
- Market Size and Forecast
- Transcranial Magnetic Stimulation (Tms) Devices
- Other Types of Neurostimulation Devices
Chapter 6 Market Breakdown by Therapeutic Application
- Global Market for Neurostimulation Devices by Therapeutic Application
- Chronic Pain
- Urinary and Fecal Incontinence
- Parkinson's Disease
- Epilepsy
- Obstructive Sleep Apnea (Osa)
- Essential Tremor
- Major Depressive Disorder (Mdd)/Clinical Depression
- Obsessive Compulsive Disorder (Ocd)
- Other Therapeutic Applications
Chapter 7 Market Breakdown by Region
- Global Market for Neurostimulation Devices by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 8 Regulatory Structure
- Regulatory Framework
- U.S.
- European Union
- Japan
Chapter 9 Key Products and Technologies on the Market
- Recent Therapeutic Improvements and New Indications
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation (Sns)
- Axonics
- Medtronic
- Vagus Nerve Stimulation
- Hypoglossal Nerve Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Other Types of Stimulation
- New Indications and Neurostimulation Therapies
Chapter 10 Emerging Technologies and Developments
- Emerging Technologies and Developments
- Closed-Loop Neurostimulation
- Non-Invasive Brain Stimulation Techniques
- High-Frequency Stimulation
- Magnetic Resonance-Guided Focused Ultrasound
- Optogenetics
- Bioelectronic Medicine
- Wireless and Remote-Controlled Devices
Chapter 12 Competitive Landscape
- Company Market Shares by Product Segment
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Vagus Nerve Stimulation Devices
- Hypoglossal Nerve Stimulation Devices
- Transcranial Magnetic Stimulation Devices
- Transcutaneous Electrical Nerve Stimulation Devices
- Recent Industry Activities
Chapter 13 Company Profiles
- Abbott Laboratories
- Aleva Neurotherapeutics Sa
- Avery Biomedical Devices Inc.
- Axonics Inc.
- Bioinduction Ltd.
- Bioventus LLC
- Biowave Corp.
- Boston Scientific Corp.
- Brainsway Ltd.
- Cochlear Americas
- Cvrx Inc.
- Electrocore Inc.
- Inspire Medical Systems Inc.
- Integer Holdings Corp.
- Laborie Inc.
- Livanova plc
- Mag & More GmbH
- Magstim Inc.
- Medtronic plc
- Nalu Medical Inc.
- Neuromed Consulting Inc.
- Neurometrix Inc.
- Neuronetics Inc.
- Neuropace Inc.
- Neurosigma Inc.
- Neurovalens Ltd.
- Nevro Corp.
- Nexstim plc
- Nyxoah Sa
- Soterix Medical Inc.
- Synapse Biomedical Inc.
- Xavant Technology (Pty) Ltd.
- Zoll Medical Corp.
List of Tables
Summary Table: Global Market for Neurostimulation Devices, by Type, Through 2028
Table 1: Prevalence of Chronic Pain and High-Impact Chronic Pain Among U.S. Adults, by Sociodemographic Characteristics, 2016
Table 2: Type of Chronic Pain, U.S
Table 3: Prevalence of Adult Overweight and Obese Population, by Country, 2014-2022
Table 4: Global Market for Neurostimulation Devices, by Type, Through 2028
Table 5: Global Market for SCS Devices, by Region, Through 2028
Table 6: Global Market for TENS Devices, by Region, Through 2028
Table 7: Global Market for DBS Devices, by Region, Through 2028
Table 8: Global Market for SNS Devices, by Region, Through 2028
Table 9: Global Market for VNS Devices, by Region, Through 2028
Table 10: Global Market for HGNS Devices, by Region, Through 2028
Table 11: Global Market for TMS Devices, by Region, Through 2028
Table 12: Global Market for Other Types of Neurostimulation Devices, by Region, Through 2028
Table 13: Global Market for Neurostimulation Devices, by Therapeutic Application, Through 2028
Table 14: Global Market for Neurostimulation Devices, by Region, Through 2028
Table 15: Regulatory Approval: U.S. vs. Europe
Table 16: Implantable Neurostimulation Devices Approved, January 2018-May 2023
Table 17: Currently Available Spinal Cord Stimulation Systems
Table 18: Currently Available Deep Brain Stimulation Systems
Table 19: Currently Available Sacral Nerve Stimulation Systems
Table 20: Currently Available Vagus Nerve Stimulation Systems
Table 21: FDA-Approved TENS Systems for Pain Relief Treatment, 2015-2021
Table 22: FDA-Approved TENS Systems for Treatment of Migraine Pain Relief, 2015-2021
Table 23: Currently Available Phrenic Nerve Stimulation Systems for Respiratory Insufficiency
Table 24: Currently Available HGNS Systems for Respiratory Insufficiency
Table 25: Currently Available Peripheral Nerve Stimulation Systems
Table 26: Currently Available Transcranial Magnetic Stimulating Systems
Table 27: Currently Available Gastric Electrical Stimulation Systems
Table 28: Neurostimulation Stimulation Product Pipeline
Table 29: Active Clinical Trials on Spinal Cord Stimulation Technology
Table 30: Active Clinical Trials on DBS Technology
Table 31: Active Clinical Trials on VNS Technology
Table 32: Active Clinical Trials on Sacral Nerve Stimulation Technology
Table 33: Active Clinical Trials on Peripheral Nerve Stimulation Technology
Table 34: Active Clinical Trials on Hypoglossal Nerve Stimulation Technology
Table 35: Shares of Companies in the Global Market for SCS Devices, 2022
Table 36: Shares of Companies in the Market for DBS Devices, 2022
Table 37: Aleva Neurotherapeutics SA: News
Table 38: Axonics Inc.: Annual Revenue, 2022
Table 39: Axonics Inc.: News
Table 40: Axonics Inc.: Product Portfolio
Table 41: Bioventus LLC: Annual Revenue, 2022
Table 42: Bioventus LLC: News
Table 43: Bioventus LLC: Product Portfolio
Table 44: Boston Scientific Corp.: Annual Revenue, 2022
Table 45: Boston Scientific Corp.: News
Table 46: Boston Scientific Corp.: Product Portfolio
Table 47: Medtronic PLC: Annual Revenue, 2022
Table 48: Synapse Biomedical Inc.: News
Table 49: Xavant Technology: Product Portfolio
Table 50: Acronyms Used in This Report
List of Figures
Summary Figure: Global Market for Neurostimulation Devices, by Type, 2020-2028
Figure 1: Global Market Shares of Neurostimulation Devices, by Type, 2022
Figure 2: Global Market for SCS Devices, by Region, 2020-2028
Figure 3: Global Market for TENS Devices, by Region, 2020-2028
Figure 4: Global Market for DBS Devices, by Region, 2020-2028
Figure 5: Global Market for SNS Devices, by Region, 2020-2028
Figure 6: Global Market for VNS Devices, by Region, 2020-2028
Figure 7: Global Market for HGNS Devices, by Region, 2020-2028
Figure 8: Global Market for TMS Devices, by Region, 2020-2028
Figure 9: Global Market for Other Types of Neurostimulation Devices, by Region, 2020-2028
Figure 10: Global Market Shares of Neurostimulation Devices, by Therapeutic Application, 2022
Figure 11: Global Market Shares of Neurostimulation Devices, by Region, 2022
Figure 12: Shares of Leading Companies in the Global Market for SCS Devices, 2022
Figure 13: Shares of Companies in the Market for DBS Devices, 2022
Figure 14: Abbott: Diagnostics Revenue, 2020-2022
Figure 15: Abbott: Diagnostics Market Share, by Business Segment, 2022
Figure 16: Abbott: Revenue Shares, by Business Unit, 2021
Figure 17: Abbott: Revenue Shares, by Market, 2021
Figure 18: Axonics Inc.: Annual Revenue, 2021 and 2022
Figure 19: Axonics Inc.: Revenue Shares, by Business Unit, 2022
Figure 20: Axonics Inc.: Revenue Shares, by Country/Region, 2022
Figure 21: Bioventus LLC: Annual Revenue, 2021 and 2022
Figure 22: Bioventus LLC: Revenue Shares, by Business Unit, 2022
Figure 23: Bioventus LLC: Revenue Shares, by Country/Region, 2022
Figure 24: Boston Scientific Corp.: Annual Revenue, 2021 and 2022
Figure 25: Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
Figure 26: Boston Scientific Corp.: Revenue Shares, by Country/Region, 2022
Figure 27: Medtronic PLC: Annual Revenue, 2021 and 2022
Figure 28: Medtronic PLC: Revenue Shares, by Business Unit, 2022
Figure 29: Medtronic PLC: Revenue Shares, by Country/Region, FY2023
